UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Affective responses to self-selected and imposed walking in inactive women with high stress: a pilot study

Journal of sports medicine and physical fitness, 2013-12, Vol.53 (6), p.701

2013

Link zum Volltext

Verfügbarkeit prüfen

Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells

The Journal of immunology (1950), 1996-07, Vol.157 (2), p.541

1996

Link zum Volltext

Verfügbarkeit prüfen

Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3

The Journal of immunology (1950), 1993-08, Vol.151 (3), p.1482

1993

Link zum Volltext

Verfügbarkeit prüfen

Up-regulation of human monocyte CD163 upon activation of cell-surface Toll-like receptors

Journal of leukocyte biology, 2007-03, Vol.81 (3), p.663-671

2007

Link zum Volltext

Verfügbarkeit prüfen

Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor Fc gamma RI (CD64) expressed on human blood dendritic cells

The Journal of immunology (1950), 1997-04, Vol.158 (7), p.3090

1997

Link zum Volltext

Verfügbarkeit prüfen

Pivotal Advance: Activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163

Journal of leukocyte biology, 2006-07, Vol.80 (1), p.26-35

2006

Link zum Volltext

Verfügbarkeit prüfen

Enhanced antigen presentation using human Fc gamma receptor (monocyte/macrophage)-specific immunogens

The Journal of immunology (1950), 1992-12, Vol.149 (11), p.3477

1992

Link zum Volltext

Verfügbarkeit prüfen

Binding of monomeric human IgG defines an expression polymorphism of Fc gamma RIII on large granular lymphocyte/natural killer cells

The Journal of immunology (1950), 1993-12, Vol.151 (11), p.6429

1993

Link zum Volltext

Verfügbarkeit prüfen

Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163

Journal of leukocyte biology, 2002-10, Vol.72 (4), p.711-717

2002

Link zum Volltext

Verfügbarkeit prüfen

HUMAN MONOCYTES EXPRESS CD163, WHICH IS UPREGULATED BY IL-10 AND IDENTICAL TO p155

Cytokine (Philadelphia, Pa.), 2000-09, Vol.12 (9), p.1312-1321

2000

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal antibody 197 (anti‐FcγRI) infusion in a patient with immune thrombocytopenia purpura (ITP) results in down‐modulation of FcγRI on circulating monocytes

British journal of haematology, 1996-03, Vol.92 (3), p.718-724

1996

Link zum Volltext

Verfügbarkeit prüfen

Increase in plasma and surface CD163 levels in patients undergoing coronary artery bypass graft surgery

Atherosclerosis, 2003-10, Vol.170 (2), p.325-332

2003

Link zum Volltext

Verfügbarkeit prüfen

Activation of human T cells by major histocompatability complex class II expressing neutrophils : Proliferation in the presence of superantigen, but not tetanus toxoid

Blood, 1997-06, Vol.89 (11), p.4128-4135

1997

Link zum Volltext

Verfügbarkeit prüfen

Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu

Journal of clinical oncology, 1995-09, Vol.13 (9), p.2281-2292

1995

Link zum Volltext

Verfügbarkeit prüfen

Development of an ELISA to measure soluble CD163 in biological fluids

Journal of immunological methods, 2001-06, Vol.252 (1), p.25-31

2001

Link zum Volltext

Verfügbarkeit prüfen

Increased potency of Fc-receptor-targeted antigens

Cancer Immunology, Immunotherapy, 1997-11, Vol.45 (3-4), p.146-148

1997

Link zum Volltext

Verfügbarkeit prüfen

Evidence for specific annexin I-binding proteins on human monocytes

Biochemical journal, 1996-06, Vol.316 ( Pt 2) (2), p.593-597

1996

Link zum Volltext

Verfügbarkeit prüfen

Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase

Journal of medicinal chemistry, 2016-05, Vol.59 (10), p.4948-4964

2016

Link zum Volltext

Verfügbarkeit prüfen

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

Nature genetics, 2009-11, Vol.41 (11), p.1238-1242

2009

Link zum Volltext

Verfügbarkeit prüfen

HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome

Oncogene, 2014-02, Vol.33 (8), p.1017-1026

2014

Link zum Volltext

Verfügbarkeit prüfen

Discovery of 3-[2-(Imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide (AP24534), a Potent, Orally Active Pan-Inhibitor of Breakpoint Cluster Region-Abelson (BCR-ABL) Kinase Including the T315I Gatekeeper Mutant

Journal of medicinal chemistry, 2010-06, Vol.53 (12), p.4701-4719

2010

Link zum Volltext

Verfügbarkeit prüfen

Crizotinib-Resistant Mutants of EML4-ALK Identified Through an Accelerated Mutagenesis Screen

Chemical biology & drug design, 2011-12, Vol.78 (6), p.999-1005

2011

Link zum Volltext

Verfügbarkeit prüfen

Non-Invasive Quantification of Cartilage Using a Novel In Vivo Bioluminescent Reporter Mouse

PloS one, 2015-07, Vol.10 (7), p.e0130564-e0130564

2015

Link zum Volltext

Verfügbarkeit prüfen

Potent activity of ponatinib (AP24534) in models of FLT3-driven acute myeloid leukemia and other hematologic malignancies

Molecular cancer therapeutics, 2011-06, Vol.10 (6), p.1028-1035

2011

Link zum Volltext

Verfügbarkeit prüfen

Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models

Molecular cancer therapeutics, 2012-03, Vol.11 (3), p.690-699

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(39)
Humans
(34)
Biological And Medical Sciences
(20)
Animals
(19)
Female
(15)
Immunology
(14)
Mice
(14)
Medical Sciences
(12)
Fundamental And Applied Biological Sciences. Psychology
(10)
Cell Line, Tumor
(8)
Biochemistry & Molecular Biology
(7)
Cell Biology
(7)
Hematology
(7)
Inflammation
(7)
Pharmacology. Drug Treatments
(7)
Protein Kinase Inhibitors - Pharmacology
(7)
Structure-Activity Relationship
(7)
Chemistry, Medicinal
(6)
Pharmacology & Pharmacy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Affective responses to self-selected and imposed walking in inactive women with high stress: a pilot study

Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells

Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte/macrophage colony-stimulating factor, IFN-gamma, and IL-3

Up-regulation of human monocyte CD163 upon activation of cell-surface Toll-like receptors

Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor Fc gamma RI (CD64) expressed on human blood dendritic cells

Pivotal Advance: Activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163

Enhanced antigen presentation using human Fc gamma receptor (monocyte/macrophage)-specific immunogens

Binding of monomeric human IgG defines an expression polymorphism of Fc gamma RIII on large granular lymphocyte/natural killer cells

Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163

HUMAN MONOCYTES EXPRESS CD163, WHICH IS UPREGULATED BY IL-10 AND IDENTICAL TO p155

Monoclonal antibody 197 (anti‐FcγRI) infusion in a patient with immune thrombocytopenia purpura (ITP) results in down‐modulation of FcγRI on circulating monocytes

Increase in plasma and surface CD163 levels in patients undergoing coronary artery bypass graft surgery

Activation of human T cells by major histocompatability complex class II expressing neutrophils : Proliferation in the presence of superantigen, but not tetanus toxoid

Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu

Development of an ELISA to measure soluble CD163 in biological fluids

Increased potency of Fc-receptor-targeted antigens

Evidence for specific annexin I-binding proteins on human monocytes

Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase

SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas

HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome

Discovery of 3-[2-(Imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide (AP24534), a Potent, Orally Active Pan-Inhibitor of Breakpoint Cluster Region-Abelson (BCR-ABL) Kinase Including the T315I Gatekeeper Mutant

Crizotinib-Resistant Mutants of EML4-ALK Identified Through an Accelerated Mutagenesis Screen

Non-Invasive Quantification of Cartilage Using a Novel In Vivo Bioluminescent Reporter Mouse

Potent activity of ponatinib (AP24534) in models of FLT3-driven acute myeloid leukemia and other hematologic malignancies

Ponatinib (AP24534), a multitargeted pan-FGFR inhibitor with activity in multiple FGFR-amplified or mutated cancer models

Aktive Filter

Suchergebnisse filtern